#and africa) embolization particle market trends
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Tumblr was the first site to host the blog for President Barack Obama in 2011.
Text
Coagulation Markers Market By Product Type, By Manufacturers, By End-User And Market Trend Analysis Forecast 2033
The Coagulation Markers Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Coagulation Markers Market: https://www.thebusinessresearchcompany.com/report/coagulation-markers-global-market-report
According to The Business Research Company’s Coagulation Markers Global Market Report 2024, The coagulation markers market size is expected to see strong growth in the next few years. It will grow to $1.52 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to a growing incidence of chronic diseases, rising adoption of personalized medicine, a growing global population, rising healthcare expenditures, and expansion in emerging markets. Major trends in the forecast period include the integration of AI and machine learning, the development of novel biomarkers, enhanced point-of-care technologies, automation in laboratories, wearable health technologies, telehealth and remote monitoring, and sustainable diagnostic practices.
The rise in the prevalence of blood disorders is expected to propel the growth of the coagulation markers market going forward. Blood disorders refer to a wide range of conditions that affect the blood's ability to function correctly. The prevalence of blood disorders is growing due to aging populations, increased awareness, and improved diagnostic capabilities. Coagulation markers help diagnose and manage blood disorders by assessing clotting function, identifying abnormalities, and monitoring treatment effectiveness for conditions like hemophilia and thrombosis. For instance, in May 2024, according to the Leukaemia Foundation, an Australia-based non-profit organization, currently around 135,000 people in Australia are living with a blood cancer or blood disorder, with this number projected to exceed 275,000 by 2035. Therefore, an increasing prevalence of blood disorders is driving the coagulation marker market.
Get A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample.aspx?id=17117&type=smp
The coagulation markers market covered in this report is segmented –
1) By Product: D-Dimer Assay, Fibrinogen Assay 2) By Sample Type: Plasma, Whole Blood Sample, Other Sample Types 3) By Technology: Fluorescence Immunoassay, Enzyme-Linked Immuno Sorbent Assay (ELISA), Rapid Test, Particle Enhanced Immunoturbidimetric Assay 4) By Application: Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Trauma, Other Applications 5) By End User: Hospital, Specialty Clinics, Academic And Research Institute, Diagnostics Laboratories
Major companies operating in the coagulation markers market are focusing on developing technologically innovative solutions, such as automated blood coagulation analyzers, to improve diagnostic accuracy, enhance efficiency, and provide faster results for better patient management. An automated blood coagulation analyzer is a medical device that automatically performs various tests to evaluate blood clotting function, providing rapid and accurate results for diagnosing and managing coagulation disorders. For instance, in July 2021, Sysmex Corporation, a Japan-based provider of in-vitro diagnostic solutions, announced the launch of its new automated blood coagulation analyzers named CN-6000 and CS-5100, designed to provide efficient and accurate coagulation testing in clinical laboratories. The CN-6000 is a fully automated coagulation analyzer with a maximum throughput of 240 tests per hour, featuring automatic sample pre-treatment, clot detection, and quality control management. The CS-5100, on the other hand, is a compact and versatile coagulation analyzer suitable for small to medium-sized laboratories, offering a throughput of up to 120 tests per hour and a user-friendly interface. Both analyzers support a wide range of coagulation assays and are designed to streamline coagulation testing workflows, improve turnaround times, and enhance patient care in clinical laboratories.
The coagulation markers market report table of contents includes:
1. Executive Summary
2. Coagulation Markers Market Characteristics
3. Coagulation Markers Market Trends And Strategies
4. Coagulation Markers Market - Macro Economic Scenario
5. Global Coagulation Markers Market Size and Growth ............
32. Global Coagulation Markers Market Competitive Benchmarking
33. Global Coagulation Markers Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Coagulation Markers Market
35. Coagulation Markers Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
0 notes
Text
Know the Latest Study of the Global Interventional Oncology Devices Market 2020 in the Industry with Prominent Players
The research report mainly introduced the global interventional oncology devices market basics: a market overview, classifications, definitions, applications, and product specifications and so on. The global analytical report has been made by using significant data research methodologies such as primary and secondary research.
Download Exclusive Sample of this Premium Report at https://market.biz/report/global-interventional-oncology-devices-market-2017-mr/177610/#requestforsample
The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with the growth of manufacturers in the global market for Interventional Oncology Devices. The report provides the readers with crucial insights on the strategies implemented by leading companies to remain in the lead of this competitive market.
Competitive landscape
Global Interventional Oncology Devices Market study covers a comprehensive competitive analysis that includes detailed company profiling of leading players, characteristics of the vendor landscape, and other important studies. Interventional Oncology Devices report explains how different players are competing in this report.
Interventional Oncology Devices Market Manufactures:
GE Healthcare
Philips Volcano
Hitachi Aloka Medical America
Medtronic
Boston Scientific
Siemens Healthineers
Market Segmentation
The global Interventional Oncology Devices market is segmented on the basis of the type of product, application, and region. The segmentation study equips interested parties to identify high-growth portions of the global Interventional Oncology Devices market and understand how the leading segments could grow during the forecast period.
Product Segment Analysis by Types
Ablation Devices
Embolization Particles
Application of Interventional Oncology Devices Market are
Lung Cancer
Kidney Cancer
Following regions are analyzed in Interventional Oncology Devices at a provincial level
North America
Europe
China
Japan
The Middle East & Africa
India
South America
Inquire more about this report @ https://market.biz/report/global-interventional-oncology-devices-market-2017-mr/177610/#inquiry
The reports help to find the answers to the following questions:
• What is the present size of the Interventional Oncology Devices Market in the top 5 Global & American countries?
• How is the Interventional Oncology Devices market separated into various product segments & sub-segments?
• How is the market expected to grow in the future?
• What is the market potential compared to other countries?
• How are the overall Interventional Oncology Devices market and different product segments developing?
References
1. Global Drywall Textures Industry Market Research Report
2. Propeller Shaft Couplings Market Is Responsible For Increasing Market Share
5 notes
·
View notes
Text
Global Embolization Particle Market Detailed Survey On Key Trends, Leading Players and Revolutionary Opportunities 2027
Global Embolization Particle Market Overview:
Global Embolization Particle Market overview, market dynamics, market characteristics, regional industry insights, country-level market statistics, major market trends, current market trends, and more are all covered in this MMR report. For the most up-to-date upgrades, the MMR report provides information on the most recent product launches by companies. The geographic insights part of the study contains data on which regions are most expected to have the largest market share over the projected period.
Global Embolization Particle Market Scope:
During the forecast period of 2021-2027, the Global Embolization Particle market is expected to grow at the fastest rate. Import and export consumption, supply and demand, costs, prices, shares, sales volumes, revenues, and gross margins are all included in the Maximize Market Research (MMR) study. This MMR data research looks at each manufacturer's manufacturing unit, capacity, production, factory price, market price, and market share.
Demand for Sample: https://www.maximizemarketresearch.com/request-sample/55903
Key Players:
• Sirtex Medical • Merit Medical • Cook Medical • BTG Medical • Boston Scientific Corporation • Terumo Corporation • HENGRUI Medical • INterface BIOmaterials B.V. • Alicon • Guerbet • Medtronics • Abbott Laboratories • Edwards Lifesciences • Johnson & Johnson • Pfizer, Inc. • St. Jude Medical, Inc.
Get More Detail: https://www.maximizemarketresearch.com/market-report/global-embolization-particle-market/55903/
Regional Analysis:
MMR Report offers information on five regions: North America, Asia Pacific, Europe, Latin America, the Middle East, and Africa. MMR analyses main market segments and sub-segments, as well as crucial market sectors, in this study. The MMR survey investigates innovative nations in neighborhood development based on market size, proportion, and quantity. Volumes, areas, sales, and marketplace chain systems and trends are among the data offered.
COVID-19 Impact Analysis on Global Embolization Particle Market:
Between 2020 and 2021, COVID-19 regulations have radically impacted the world, as well as industry and labor expectations. COVID-19 has the potential to destabilize our social and living standards, needing rapid innovation and industrial support. COVID-19 has caused various problems for migrant workers in India. Millions of migrant workers lost their jobs, faced food shortages, and were frightened about their future prospects as a result of national embargoes.
The overall goal of this MMR report is to better comprehend the current economy, COVID-19, and its impact on business. MMR is tracking COVID-19 across all industries, sectors, and specialties. Similar data may be found in the Maximize Market Research Report (MMR), which can be used to analyze how COVID-19 has impacted industry losses and growth.
Key Questions answered in the Global Embolization Particle Market Report are:
Which product segment grabbed the largest share in the Global Embolization Particle market?
How is the competitive scenario of the Global Embolization Particle market?
Which are the key factors aiding the Global Embolization Particle market growth?
Which region holds the maximum share in the Global Embolization Particle market?
What will be the CAGR of the Global Embolization Particle market during the forecast period?
Which application segment emerged as the leading segment in the Global Embolization Particle market?
Which are the prominent players in the Global Embolization Particle market?
What key trends are likely to emerge in the Global Embolization Particle market in the forecast period?
What is the expected Global Embolization Particle market size by 2027?
Which company held the largest share in the Global Embolization Particle market?
About Us:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT Park Phase 2,
Pune Banglore Highway,
Narhe, Pune, Maharashtra 411041, India.
Email: [email protected]
Phone No.: +91 20 6630 3320
Website: www.maximizemarketresearch.com
Related Link: https://www.maximizemarketresearch.com/market-report/global-neuroendoscopy-devices-market/85110/ https://www.maximizemarketresearch.com/market-report/global-rheumatoid-arthritis-diagnosis-market/112472/ https://www.maximizemarketresearch.com/market-report/healthcare-analytics-market/2877/ https://www.maximizemarketresearch.com/market-report/global-lithium-silicate-market/72848/ https://www.maximizemarketresearch.com/market-report/global-miticides-market/17077/
0 notes
Text
PVA Embolization Particles Market Forecast and Prognostication to (2020-2025)
The PVA Embolization Particles research report provides key data of the market status in terms of PVA Embolization Particles size estimates and forecasts, rate of growth. This report also covers key players of the market point out through their market share, product offerings. Further, the PVA Embolization Particles research report strategical insights supported assessment of recent developments, strategy analysis of the players. It also covers drivers, opportunity and challenges prevailing within the industry.
Request Free Sample Copy of Research Report at: https://optimusmarketreports.com/request-sample/1823
The information available within the global PVA Embolization Particles market report isn't only supported the facts but also on the case studies, which analysts have included to deliver appropriate information to the clients during a well-versed manner. Moreover, for better understanding, the report includes statistical figures, graphs, tables, and charts associated with the knowledge mentioned in textual form. The report also provides the market dynamics like drivers, restraints, strategies & guidelines, trends, avenues, and technological improvements anticipated to possess an impression on the PVA Embolization Particles Market growth within the projected period.
Key Players in the global PVA Embolization Particles market covered in Reports:
Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials, Alicon
Key Types in the global PVA Embolization Particles market covered in Reports:
Conventional/Irregular PVA
Compressible and Spherical PVA
Key Applications in the global PVA Embolization Particles market covered in Reports:
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Request for Discount of Research Report at: https://optimusmarketreports.com/request_discount/1823
Regions & Countries Mentioned within the PVA Embolization Particles Report:
North America (United States)
Europe (Germany, France, UK)
Asia-Pacific (China, Japan, India)
Latin America (Brazil)
The Middle East & Africa
Key questions answered through this market research report:
What Are Market PVA Embolization Particles Market? What Are Challenges and Opportunities?
What Should Be Entry Strategies, Counter measures to Economic Impact, Marketing Channels for PVA Embolization Particles Industry?
Who Are the worldwide Key Players during this PVA Embolization Particles Market?
What’s marketing research of PVA Embolization Particles Market by Taking Applications and kinds in Consideration?
what's Economic Impact on PVA Embolization Particles Industry?
Get Customized Report as per Your Business Requirement: https://optimusmarketreports.com/customize_request/1823
About Us
Optimus Market Research is a premium market research report provider.We have successfully delivered research reports to greater than 800+ global clients.Our primary goal is to achieve in depth research analysis to help our clients with the most accurate business insights.We provide actionable insights through reports to make the right business decisions.OMR believes in giving you the perfect solution for your investment and therefore we interact with the clients to identify their principal needs and prepare real-time data to match them. Likewise we not only help by providing reports but also help them come up with ideas that would make them unique and unprecedented so that they may come at par or even overthrow your market competition.
Contact Us
https://optimusmarketreports.com//
0 notes
Text
Embolization Particles Market Size, Growth & Analysis, By Product Type, By End-User, And Regional Forecasts To 2027
The study of the Embolization Particles market by Reports and Data offers a comprehensive overview of the market size and trends of the Embolization Particles market on a global and regional scale. The report also provides an assessment of the factors and parameters that have the potential to impact the growth and expansion of the market. The insightful information offered by the report assists in making profitable business decisions and formulate strategic investment plans to gain maximum returns. In addition to this, the study is equipped with a detailed analysis of the companies to help the readers understand the competitive scope of the market. The Global Embolization Particles Market is expected to grow at a CAGR of roughly 14.7% over the next five years, will reach USD 3.93 billion in 2027, from USD 1.17 billion in 2019.
Furthermore, the report also covers a thorough analysis of the key factors influencing the market growth. The report considers the COVID-19 pandemic as one of the major factors affecting the expansion of the market. The pandemic has affected the market directly by disrupting the global supply chains, halting the manufacturing and production processes, and altering the economic landscape of the market. The report also offers a current and future assessment of the impact of the pandemic on the Embolization Particles market.
Some of the key players operating in the Embolization Particles market are Boston Scientific Corporation, Abbott Laboratories, Cook Medical, Inc., BTG plc, Edwards Lifesciences, Sirtex Medical Limited, Johnson & Johnson, Pfizer, Inc., St. Jude Medical, Inc., and Terumo Corporation.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3565
The report aims to provide an in-depth analysis of the competitive landscape with profiles of key market competitors. The report provides a comprehensive analysis of the competitive landscape, along with a detailed analysis of the mergers, acquisitions, joint ventures, partnerships, collaborations, and other strategic alliances. It covers extensive analysis of the competitors along with their business expansion plans, product launches and brand promotions, and the advancements in the manufacturing processes and product portfolio.
The report also provides an extensive analysis of the latest product developments, technological advancement, and advancements research and developments in the global Embolization Particles industry. The report provides forecast estimations about the market’s scope for the years 2020-2027. The cumulative information about crucial segments provides a thorough analysis to the reader that might assist them in achieving expected growth for their business.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3565
By Product Type (USD Million, 2017 – 2027)
Radioembolization Spheres
Microspheres
Drug-Eluting Beads
PVA Particles & Gelfoam Particles
Other Particles
By Application (USD Million, 2017 – 2027)
Peripheral Vascular Disease
Neurology
Oncology
Urology
Others
By End-user (USD Million, 2017 – 2027)
Hospitals & Clinics
Ambulatory Centers
Others
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/embolization-particles-market
The report covers all the investment opportunities, market dynamics, threats, opportunities, challenges, restraining factors, and technological advancements in the global Embolization Particles market. The report covers key regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report provides extensive details about the production and consumption pattern, supply and demand ratio, sales, market share and size, and the existence of the key players in each region. The report also offers an estimation regarding the key regions expected to demonstrate a significant growth rate over the coming years.
The regional analysis covers the following regions of the key geographies of the Embolization Particles market:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Thank you for reading our report. To inquire about customization or any queries about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W Head of Business Development Direct Line: +1-212-710-1370 E-mail: [email protected] Reports and Data | Web: www.reportsanddata.com News: www.reportsanddata.com/market-news Connect with us: Facebook | Google+ | LinkedIn | Twitter
0 notes
Text
Trans catheter Embolization and Occlusion Market Innovations, Emerging Trends, Growth, Future Growth & Forecast
Global Transcatheter Embolization And Occlusion Market is set to witness a substantial CAGR of 9.5% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing cases of cancer and rising healthcare technology are the factors contribution towards the growth of this market.
Embolization is the natural or artificial formation and development of embolus in the bloodstream and occlusion is the closure of any blood vessel or organs. The embolization technique is usually used for the treatment of cancer, malformations and fibrosis. Transcatheter embolization is a process which usually uses synthetic material into a blood vessel so that they can stop the flow of blood into a specific area of the body.
Get | Exclusive Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transcatheter-embolization-and-occlusion-market
Competitive Analysis:
Global transcatheter embolization and occlusion market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of transcatheter embolization and occlusion market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Competitors:
Few of the major competitors currently working in the global transcatheter embolization and occlusion market are BTG International Ltd., Boston Scientific Corporation, Medtronic, Penumbra, Inc, Cook, Edwards Lifesciences Corporation, Merit Medical Systems, Johnson & Johnson Services, Inc, Pfizer Inc., Stryker, Terumo Corporation, Sirtex Medical, Abbott among others.
Inquiry about Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-transcatheter-embolization-and-occlusion-market
Segmentation: Global Transcatheter Embolization and Occlusion Market
By Device Type (Coil, Non Coil), Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, Others)
By Product (Liquid Embolics, Embolization Particles, Flow Diverter Devices, Embolization Coils, Accessories)
By End- User (Clinics, Hospitals, Ambulatory Surgical Centers), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
Reasons to Purchase this Report
Current and future of global anesthesia monitoring market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Key Insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key market players involved in this industry
Detailed analysis of the market segmentation
Competitive analysis of the key players involved
Browse full report @ https://www.databridgemarketresearch.com/reports/global-transcatheter-embolization-and-occlusion-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Related Reports:
Global Patch Based Wound Healing Products Market
Global Cell-Based Immunotherapy Market
0 notes
Text
Interventional Oncology Solutions Market - Industry Analysis, Size, Share, Trends, Demand, Overview, Forecast 2026
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat cancer in pancreas, liver, lung, breast, prostrate, kidney, and bones. Interventional oncology procedures are segmented into two procedures i.e. diagnostic and therapeutic. Therapeutic procedures can be further categorized into ablation techniques and embolization techniques. Ablation techniques uses some form of heat to destroy tumor. Embolization Technique occludes blood vessels, which feed tumors and further destroy the tumor by means of ischemia. Both these procedures are minimally invasive and there is minimal pain, complications, and discomfort with rapid recovery.
Interventional Oncology Solutions Market Drivers:-
Increasing popularity of minimal invasive procedures due to advantages such as minimal risk of infection, shorter stay in the hospitals, minimal complications, minimal pain, and faster recovery as compared to invasive surgeries, is a major factor supporting the global interventional oncology solutions market growth over the forecast period. Moreover, increasing product launches is expected to aid in growth in interventional oncology solutions market size. For instance, in 2017, Terumo Corporation, a Japan-based company, launched Quirem Spheres microspheres. This is used to treat solid liver tumors, which cannot be removed by surgery completely. Microspheres consists of a radioactive isotope Holium-166. Quirem Spheres and can also be visualized in low concentrations by means of SPECT (Single Photon Emission Computed Tomography) and MRI. This feature allows doctors to carefully assess distribution of microspheres in the organs such as liver, which enables in accurate assessment of treatment after SIRT (Selective Internal radiation Therapy) procedure. Half-life of Quirem Spheres is 26.8 hours, which means that within the first 4 days more than 90% of the radiation is delivered, which is followed by implantation procedure.
Interventional Oncology Solutions Market Regional Analysis:-
North America is expected to hold dominant position in the global interventional oncology solutions market over the forecast period. This is owing to increasing mergers & acquisition and research collaboration between manufacturers and universities in the region to develop novel products. For instance, in 2015, Boston Scientific enhanced its interventional oncology portfolio by acquiring spherical embolic technologies, Embozene and Oncozene microspheres, which were developed by Celo Nova Biosciences. These spheres are designed to prevent flow of blood to the targeted tissue and also reduce growth of tumors. Moreover, in 2016, Philips collaborated with Yale School of Medicine to bring new innovations in the field of interventional oncology. Liver cancer is one of their main focus areas, as TACE (Trans arterial Chemoembolization), an alternative and minimally invasive technique to treat liver cancer patients, it has shown better results than chemotherapy. TACE is a minimally invasive procedure which is performed in interventional radiology to restrict a tumors blood supply. Small embolic particles which are coated with chemotherapeutic drugs are injected through a catheter into the arteries which supply blood to the tumor. Chemotherapeutic drugs block the supply of blood and induce cytotoxicity i.e. attacking the tumor in several ways. TACE involves administration of embolic beads and chemotherapy agents to gradually block arteries feeding the tumor, which further causes death of the tumor.
Europe interventional oncology solutions market is expected to exhibit high growth over the forecast period, owing to high cancer prevalence in the region. According to a study conducted by World Health Organization (WHO) in 2016, Europe has over 753,600 people diagnosed with cancer. Furthermore, key players in the region are focusing on launching new products, which is another factor supporting growth of the market. For instance, in 2017, Elekta, a Sweden-based company, launched Elekta Unity MR-linac, which relies on a Philips 1.5 Tesla MRI Machine. During therapy sessions, the machine produces diagnostic level image quality. This device provides more precise treatment, which includes targeting of higher doses on sensitive areas containing multiple organs and also observation of radiation affecting tumor. One of the most important application of this device is the functional MRI, which helps doctor to observe how the treatment is working on the tumor and it also helps to evaluate the rate of blood flow through the tumor, which indicates if the tissue is alive or is showing some change due to the therapy.
Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/1884
Interventional Oncology Solutions Market Key Players:-
Key players operating in the global interventional oncology solutions market include Boston Scientific Corporation, Angio Dynamics, C.R. Bard, Best Medical International, Pfizer, MedWaves, Health Tronics, Sitex, BTG, Merit Medical Systems, Perseon, Cook Medical, Accuracy, Vascular Solutions, TERUMO, ALPINION MEDICAL SYSTEMS, Varian medical, Smith & Nephew, Profound Medical, BOVIE MEDICAL, and Baylis Medical.
Interventional Oncology Solutions Market Taxonomy:-
By Therapy-
Radiation Therapy
External Radiation Therapy
Internal Radiation Therapy
Ablation
Radiofrequency Ablation
Cryo Ablation Therapy
Microwave Ablation Therapy
Particle Embolization
Radio Embolization
Microspheres
Drug Eluting Beads
Polyvinyl Alcohol Particles
By End Users:-
Hospitals
Specialty Clinics
Ambulatory Surgery Centers
Others
By Region:-
North America
Europe
Latin America
Asia Pacific
Middle East
Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
0 notes
Text
Embolization Particle Market Necessity And Demand 2018 to 2026
Coherent Market Insights added Latest Research Report titled " Embolization Particle Market, by Product type (Radioembolization Spheres, Microspheres, Drug Eluting Beads, PVA Particles & Gelfoam Particles, and Other Particles), by Application (Peripheral Vascular Disease, Neurology, Oncology, Urology, and Others), by End User (Hospitals & Clinics, Ambulatory Centers, and Others) and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) — Size, Share, Outlook, and Opportunity Analysis, 2018–2026 " to its Large Report database.
Embolization is a minimally invasive therapy in which an embolus is injected to stop bleeding or to cut off the supply of blood to a tumor in order to shrink it for preparation of its removal. Embolization is used in various interventional radiology procedures. In this procedure, an interventional radiologist uses image guidance to insert the catheter into a primary artery and advance it to vessel leading to a tumor or other part where the blood supply needs to be blocked. Embolization is an option for some patients with tumors that cannot be removed by surgery. It can be used for tumors that are usually larger than 5 cm thickness and cannot be removed by ablation. This procedure is used to treat various types of cancerous tumors, hemorrhages, along with the management of malignant hypertension caused by renal failure.
Embolization Particle Market - Market Dynamics
The market for embolization particle is driven by factors such as increasing prevalence of various types of cancer.
Embolization particles are the crucial product used in the treatment of malignancies such as cancer, peripheral diseases, and others. Rising prevalence of cancer globally, has supported growth of the embolization particle market. According to World Health Organization (WHO), cancer is the second prominent cause of death across the globe, and around 9.6 million deaths occurred due to cancer in 2018. Moreover, as per the Cancer Research UK, over 17 million new cases were estimated to occur in year 2018 around the globe. The burden of cancer is increasing rapidly in the U.S. with the incidence of 439.2 per 100,000 men and women per year as according to National Cancer Institute (2015).
Embolization Particle Market – Competitive Landscape
Major players operating in the embolization particle markets include, Abbott Laboratories, Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Pfizer, Inc., Sirtex Medical Limited, St. Jude Medical, Inc., and Terumo Corporation.
Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/2374
Embolization Particle Market Taxonomy
On the basis of product type, the global embolization particle market is segmented into:
Radioembolization Spheres
Microspheres
Drug Eluting Beads
PVA Particles & Gelfoam Particles
Other Particles
On the basis of application, the global embolization particle market is segmented into:
Peripheral Vascular Disease
Neurology
Oncology
Urology
Others
On the basis of end-user, the global embolization particle market is segmented into:
Hospitals & Clinics
Ambulatory Centers
Others
On the basis of treatment, the global embolization particle market is segmented into:
Urethral Dilation
Direct Vision Internal Urethrotomy (DVIU)
Urethroplasty
Others
Embolization Particle Market – Regional Insights
On the basis of geography, the global embolization particle market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America would be dominant region in the global embolization particle market in 2017. This is owing to the strong economic condition, huge expansion of healthcare domain, and increasing focus of research institutions on modernizing technology for new and advanced diagnosis and treatment methods. Moreover, unique hospital infrastructures, and availability of skilled healthcare professionals is further aiding growth of the market.
On the other hand, Asia Pacific is expected to witness significant growth in embolization particle market during the forecast period, owing to increasing patient population (mainly cancer) in emerging economies such as India. For instance, according to Indian Council Medical Research (ICMR), it is expected that over 17.3 lakh new cancer cases and over 8.8 lakh deaths will occur in India due to cancer by 2020. Moreover, growing focus by government on enhancing healthcare facilities and booming medical tourism is expected to boost growth of the embolization particle market in this region.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
#Embolization Particle Market#Embolization Particle Market size#Embolization Particle Market trends#Embolization Particle Market outlook
0 notes
Text
Transcatheter Embolization and Occlusion Devices Market – Size, Growth and Trends Analysis 2018–2026
Transcatheter embolization and occlusion refers to passage or insertion of a synthetic embolus through a fine catheter in the blood vessel to obstruct the blood flow in particular area of the body. Transcatheter embolization is a minimally invasive procedure performed as a part of interventional radiology to restrict blood supply to tumors. Synthetic materials known as embolic agents, in some cases, are coated with chemotherapeutic drugs that perform dual action of blocking the blood supply as well as inducing cytotoxicity to attack the tumor in several ways. Moreover, this procedure is also employed to control or prevent abnormal bleeding, eliminate abnormal connections between arteries and veins as well as to treat aneurysms, which refers to formation of a bulge or a sac in weak arterial wall.
Browse Full Report: https://www.coherentmarketinsights.com/ongoing-insight/transcatheter-embolization-and-occlusion-devices-market-1683
Transcatheter embolization is a less invasive and highly efficient way to control bleeding as compared to open invasive surgical procedures. Catheter embolization is considered to be the first line of treatment in gastrointestinal bleeding. This process can be performed alone or combined with other treatments such as surgery or radiation. The process is initiated with the help of x-ray imaging to visualize the blood vessel, after which an interventional radiologist inserts a catheter to the skin into the desired blood vessel and advanced to the treatment site. Among females, this method provides an excellent alternative to hysterectomy to shrink and control heavy menstrual bleeding by interrupting the blood supply caused due to uterine fibroid tumors.
Market Dynamics
Increasing demand for minimally invasive surgical procedures over conventional open surgeries is expected to propel growth of transcatheter embolization and occlusion devices market. This shift is a result of advantages offered by minimally invasive procedures over open surgeries that includes significantly low blood loss, low recovery time, low surgical time, reduced probability of errors, and others. For instance, according to a retrospective review published by Department of Surgery, John Hopkins Hospital, in 2014, it suggested that the complication and error rates for hysterectomy was 4.69% and 6.64% in catheter embolization and open surgical procedures, respectively.
According to the American Association of Neurological Surgeons 2017, the prevalence of arteriovenous malfunctions (AVM) is estimated at 18 people per 100,000 population in the U.S. Moreover, the AVM is reported to be the second most identifiable cause for subarachnoid hemorrhage. Furthermore, leading players in the market are introducing novel products in the market and this is also expected to aid in growth of the market in the region. For instance, in September 2017, Medtronic Plc expanded its embolization product portfolio with the introduction of Concerto 3D detachable system in the U.S. and Europe that can be used in arterial and venous embolization.
Competitive Insights
Key players operating in the global transcatheter embolization and occlusion devices market include Boston Scientific Corporation, Terumo Corporation, Cook Medica, DePuy Synthes, Edwards, Eisai, Medtronic Plc, Merit Medical System, Stryker Corporation, St. Jude Medical, Pfizer, Inc., Sirtex Medical, Nordian, and others. Market players are focused on providing technologically advanced products, to sustain their position in the competitive market. For instance, in January 2018, Johnson & Johnson’s Cerenovous division introduced Galaxy G3 Mini embolic coil to remove clots from brain post ischemic strokes.
Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1683
Market Taxonomy
On the basis of device type, the global transcatheter embolization and occlusion devices market is segmented into: Coiled Devices, Pushable Coils, Detachable Coils, Non-Coiled Devices, Flow Diverting Devices, Embolization Particles, Liquid Embolics, Other Embolization and Occlusion Devices, Accessories,. On the basis of end user, the global transcatheter embolization and occlusion devices market is segmented into: Hospitals, Clinics, Ambulatory Surgical Centers, Others,. On the basis of region, the global transcatheter embolization and occlusion devices market is segmented into: North America, Latin America, Europe, Asia Pacific, Middle East, Africa,.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
Visit our news Website: https://www.coherenttimes.org
0 notes
Text
Embolization Particle Market Share, Size, Regional Trend, Future Growth, Leading Players Updates, Current And Future Plans
Embolization Particle Market Overview:
The study covers the Embolization Particle market's most recent revenue and market trends. It stresses a market overview, definition, and structure, as well as preventative and pre-planned management. The report focuses on the factors that influence the Embolization Particle Market, such as gross margin, cost, market share, capacity utilisation, and supply. It also aids in determining the future potential of Embolization Particle Market in the next years. The report presents a market overview through common subjects that are highlighted with unique data based on the need. This overview aids in making decisions about how to approach the market and comprehending the industry's backdrop.
Request for free sample: https://www.maximizemarketresearch.com/request-sample/55903
Market Scope:
Key Market Trends & Challenges:
The study analyses the primary adoption trend impacting the Embolization Particle industry as well as issues that may stymie its expansion. Understanding these elements is critical for product planning and design, as well as commercial strategies. To assist you understand the Embolization Particle market, this study provides a full analysis of these trends and obstacles.
Market Statistics:
The report provides the market size and share of the Embolization Particle market. It helps in understanding the market and the report estimates upfront data and statistics that make the report a very valuable guide for individuals dealing with advertising and industry decision-making processes in the Embolization Particle market.
Get more Report Details: https://www.maximizemarketresearch.com/market-report/global-embolization-particle-market/55903/
Key Players:
• Sirtex Medical • Merit Medical • Cook Medical • BTG Medical • Boston Scientific Corporation • Terumo Corporation • HENGRUI Medical • INterface BIOmaterials B.V. • Alicon • Guerbet • Medtronics • Abbott Laboratories • Edwards Lifesciences • Johnson & Johnson • Pfizer, Inc. • St. Jude Medical, Inc.
The report examines the top players in the Embolization Particle market in terms of their size, market share, market growth, revenue, production volume, and profitability. The research outlines which growth strategies are being used by key players, including strategic alliances, new product innovation, and so on. It tells you whether you're competing with only industry firms or with competitors who provide alternative solutions. The study helps you understand competitor pricing in the Embolization Particle market so you can examine and build a pricing plan that works for your product. The competitive landscape is a significant feature of the Embolization Particle industry that all key stakeholders in the industry should be aware of.
Regional Analysis:
Geographically, this report is segmented into several key countries, with market size, growth rate, import and export of Embolization Particle market in these countries, which covering North America, U.S., Canada, Mexico, Europe, UK, Germany, France, Spain, Italy, Rest of Europe, Asia Pacific, China, India, Japan, Australia, South Korea, ASEAN Countries, Rest of APAC, South America, Brazil, and Middle East and Africa.
COVID-19 Impact Analysis on Embolization Particle Market:
The report has identified detailed impact of COVID-19 on Embolization Particle market in regions such as North America, Asia Pacific, Middle-East, Europe, and South America. The report provides Comprehensive analysis on alternatives, difficult conditions, and difficult scenarios of Embolization Particle market during this crisis. The report briefly elaborates the advantages as well as the difficulties in terms of finance and market growth attained during the COVID-19. In addition, report offers a set of concepts, which is expected to aid readers in deciding and planning a strategy for their business.
Key Questions answered in the Embolization Particle Market Report are:
Which product segment grabbed the largest share in the Embolization Particle market?
How is the competitive scenario of the Embolization Particle market?
Which are the key factors aiding the Embolization Particle market growth?
Which region holds the maximum share in the Embolization Particle market?
What will be the CAGR of the Embolization Particle market during the forecast period?
Which application segment emerged as the leading segment in the Embolization Particle market?
Which are the prominent players in the Embolization Particle market?
What key trends are likely to emerge in the Embolization Particle market in the coming years?
What will be the Embolization Particle market size by 2027?
Which company held the largest share in the Embolization Particle market?
About Us:
Maximize Market Research provides B2B and B2C research on 12000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors.
Contact Us:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT Park Phase 2,
Pune Bangalore Highway,
Narhe, Pune, Maharashtra 411041, India.
Email: [email protected]
Phone No.: +91 20 6630 3320
Website: www.maximizemarketresearch.com
0 notes
Link
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells. Scope of the Report: This report focuses on the Embolization Particle in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Sirtex Medical Merit Medical Cook Medical BTG Medical Boston Scientific Corporation Terumo Corporation HENGRUI Medical INterface BIOmaterials B.V. Alicon Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Microspheres Particles (e.g. PVA Particles, Gelfoam Particles) Drug-eluting Beads (DEBs) Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Market Segment by Applications, can be divided into Uterine Fibroid Embolization Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Liver Tumor Embolization Trauma Embolization Other There are 15 Chapters to deeply display the global Embolization Particle market. Chapter 1, to describe Embolization Particle Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Embolization Particle, with sales, revenue, and price of Embolization Particle, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Embolization Particle, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Embolization Particle market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Embolization Particle sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
#(north america#asia-pacific#america#and africa) embolization particle market#and africa) embolization particle market trends#and africa) embolization particle market size#and africa) embolization particle market data#and africa) embolization particle market structure#and africa) embolization particle industry analysis#and africa) embolization particle market research
0 notes
Text
PVA Embolization Particles Market Size, Global Statistics Analysis Overview, Industry Insights and COVID-19 Pandemic Presenting Future Opportunities 2027
"
PVA Embolization Particles Market is analyzed with industry experts in mind to maximize return on investment by providing clear information needed for informed business decisions. This research will help both established and new entrants to identify and analyze market needs, market size and competition. It explains the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities and the threats faced by key players.
Sample Copy of This Report:https://axelreports.com/request-sample/143976
A 360 degree outline of the competitive scenario of the Global PVA Embolization Particles Market is presented by Axel Reports Market Insights. It has a massive data allied to the recent product and technological developments in the markets.
It has a wide-ranging analysis of the impact of these advancements on the market’s future growth, wide-ranging analysis of these extensions on the market’s future growth. The research report studies the market in a detailed manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period.
Reasons for buying this report:
It offers an analysis of changing competitive scenario.
For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.
It offers seven-year assessment of Global PVA Embolization Particles
It helps in understanding the major key product segments.
Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.
It offers regional analysis of Global PVA Embolization Particles Market along with business profiles of several stakeholders.
It offers massive data about trending factors that will influence the progress of the Global PVA Embolization Particles
Get ToC for the overview of the premium report @ https://axelreports.com/industry-analysis/global-pva-embolization-particles-industry-research-report-2021-segmented-by-major-market/143976
By Market Verdors: Sirtex Medical Merit Medical Cook Medical BTG Medical Boston Scientific Corporation Terumo Corporation HENGRUI Medical INterface BIOmaterials Alicon By Types: Conventional/Irregular PVA Compressible and Spherical PVA By Applications: Uterine Fibroid Embolization Prostatic Artery Embolization Liver Tumor Embolization Trauma Embolization Other
A detailed outline of the Global PVA Embolization Particles Market includes a comprehensive analysis of different verticals of businesses. North America, Latin America, Asia-Pacific, Africa, and Europe have been considered for the studies on the basis of several terminologies.
This is anticipated to drive the Global PVA Embolization Particles Market over the forecast period. This research report covers the market landscape and its progress prospects in the near future. After studying key companies, the report focuses on the new entrants contributing to the growth of the market. Most companies in the Global PVA Embolization Particles Market are currently adopting new technological trends in the market.
Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global PVA Embolization Particles Market. The feasibility of the new report is also measured in this research report.
Make an Enquiry for purchasing this Report :https://axelreports.com/enquiry-before-buying/143976
Table of Contents:
Global PVA Embolization Particles Market Overview
Economic Impact on Industry
Market Competition by Manufacturers
Production, Revenue (Value) by Region
Production, Revenue (Value), Price Trend by Type
Market Analysis by Application
Cost Analysis
Industrial Chain, Sourcing Strategy and Downstream Buyers
Marketing Strategy Analysis, Distributors/Traders
Market Effect Factors Analysis
Global PVA Embolization Particles Market Forecast
ABOUT US:
Axel Reports has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.
Contact: Axel Reports Akansha G (Knowledge Partner) Office No- B 201 Pune, Maharashtra 411060 Phone: US +18488639402 Email: [email protected]/ Web: https://axelreports.com/
"
0 notes
Text
Global Transcatheter Embolization Device Market Overview, Strategies, COVID-19 Impact Forecast 2021-2027
Transcatheter Embolization Device Market overview:
The statistical surveying report comprises of a detailed study of the Transcatheter Embolization Device Market 2021 along with the industry trends, size, share, growth drivers, challenges, competitive analysis, and revenue. The report also includes an analysis on the overall market competition as well as the product portfolio of major players functioning in the market. To understand the competitive scenario of the market, an analysis of the Porter’s Five Forces model has also been included for the market.
Major Manufacturer Detail: Boston Scientific , Edwards Lifesciences , Medtronic , Neovasc , MitrAssist , Micro Interventional Devices,
Get a Sample Report @: https://www.garnerinsights.com/Global-Transcatheter-Embolization-Device-Market-Trends-By-Regional-Analysis-America-Europe-Asia-Pacific-and-Middle-East–Africa-Growth-Opportunity-and-Industry-Forecast-2021-2027#request-sample
The Important Type Coverage of Transcatheter Embolization Device market: Particle embolic , Coil embolic , Liquid embolic , Others
Segment by Applications of Transcatheter Embolization Device market: Heart , Lung , Others
The novel COVID-19 pandemic has put the world on a standstill, affecting major operations, leading to an industrial catastrophe. This report presented by Garner Insights contains a thorough analysis of the pre and post pandemic market scenarios. This report covers all the recent development and changes recorded during the COVID-19 outbreak.
Enquire Here For Discount @ https://www.garnerinsights.com/Global-Transcatheter-Embolization-Device-Market-Trends-By-Regional-Analysis-America-Europe-Asia-Pacific-and-Middle-East–Africa-Growth-Opportunity-and-Industry-Forecast-2021-2027#discount
Some of the main geographies included in this study: North America (United States and Canada and rest of North America) Europe (Germany, France, Italy and rest of Europe)
Table of Contents:
Study Coverage: It includes key manufacturers covered, key market segments, the scope of products offered in the global Transcatheter Embolization Device market, years considered, and study objectives. Additionally, it touches the segmentation study provided in the report on the basis of the type of product and application.
Executive Summary: It gives a summary of Transcatheter Embolization Device market key studies, market growth rate, competitive landscape, market drivers, trends, and issues, and macroscopic indicators.
Production by Region: Here, Transcatheter Embolization Device market report provides information related to import and export, production, revenue, and key players of all regional markets studied.
Profile of Manufacturers: Each player profiled in this section is studied on the basis of SWOT analysis, their products, production, value, capacity, and other vital factors in Transcatheter Embolization Device market.
Reasons to buy:
In-depth analysis of the market on the global and regional level.
Major changes in market dynamics and competitive landscape of Transcatheter Embolization Device market.
Segmentation on the basis of type, application, geography and others.
View Full Report of Transcatheter Embolization Device market@ https://garnerinsights.com/Global-Transcatheter-Embolization-Device-Market-Trends-By-Regional-Analysis-America-Europe-Asia-Pacific-and-Middle-East–Africa-Growth-Opportunity-and-Industry-Forecast-2021-2027
About Us: Garner Insights is a Market Intelligence and consulting firm with an all-inclusive experience and vast knowledge of the market research industry.Our vast storage of research reports across various categories, gives you a complete view of the ever changing and developing trends and current topics worldwide. Our constant endeavor is to keep on improving our storage information by providing rich market reports and constantly improving them.
Contact Us: Mr. Kevin Thomas +1 513 549 5911 (US) +44 203 318 2846 (UK) Email: [email protected]
from NeighborWebSJ https://ift.tt/3t3Qw96 via IFTTT
from WordPress https://ift.tt/2PRttzP via IFTTT
0 notes
Text
U.S. Uterine Fibroid Treatment Market Latest Research On Industry Growth, Trends, Top Players, & Key Regions By 2027
Uterine fibroids are muscle tumors formed in the uterus. If these are large in size, then they may push on to the bladder that causes frequent urge to urinate. Uterine fibroid treatment involves providing medications for uterine fibroids target hormones that regulate women’s menstrual cycle, and treating symptoms, such as heavy menstrual bleeding and pelvic pressure. They don't eliminate fibroids, but may shrink them. Medications include gonadotropin-releasing hormone (GnRH) agonists. The demand for uterine fibroid treatment is also rising owing to the high incidence of uterine fibroids among women, coupled with the emergence of effective treatment for uterine fibroid.
Magnetic Resonance-guided Focused Ultrasound (MRgFUS) is a noninvasive, incisionless technique used to treat abnormal benign growths in a woman's uterus called fibroid tumors or fibroids. Uterine fibroids are very common, occurring in approximately one in four women, and often have no symptoms.
Key Insights:
Latest Updates
Analyst Views
Future Outlook of the Market
Get Free PDF Brochure of this Report @ https://www.fostermarketresearch.com/product/industry/10/22/Pdf%20Brochure/
Competitive Landscape:
Key players in the U.S. uterine fibroid treatment market include Blue Endo, Boston Scientific Corporation, Cooper Surgical, Inc., Karl Storz SE & Co. KG, Myovant Sciences (Sumitovant Biopharma Ltd.), Halt Medical, Inc., LiNA Medical USA, Merit Medical Systems, Olympus Corporation, and Richard Wolf GmbH, among others.
The market is competitive with a number of major as well as small and medium enterprises (SMEs). The strategies adopted by the SME are product innovation and development to gain the market share whereas major players have adopted the strategy of joint venture and acquisition to strengthen their position in the global market. For instance, in April 2020, Myovant Sciences, which is one of five healthcare companies in the Sumitovant Biopharma Ltd, focused on redefining care for women's health and prostate cancer has published three summaries that provide information about safety and efficacy from the third phase of LIBERTY 1 and 2 studies of the relugolix combination therapy for women suffering from heavy menstrual bleeding associated with uterine fibroids.
Market Taxonomy:
By Procedure Type
Endometrial Ablation
MRI Guided ProceduresMRI-guided Percutaneous Laser Ablation MRI-guided Transcutaneous Focused Ultrasound
HysterectomyAbdominal Hysterectomy Vaginal Hysterectomy Laparoscopic Hysterectomy Robotic Hysterectomy Hysteroscopic Morcellation
MyomectomyOpen Myomectomy Laparoscopic Myomectomy Robotic Myomectomy
Uterine Artery Embolization
Radiofrequency Ablation
Others
By End User
Hospitals
Ambulatory Surgical Centers (AScs)
Key Region Covered in U.S. Uterine Fibroid Treatment Market are
North America (USA, Canada, and Mexico)
Europe (Germany, France, the United Kingdom, Netherlands, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, rest of countries, etc.)
The Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Nigeria, and South Africa)
For More Information of this Report @https://www.fostermarketresearch.com/product/industry/10/22/
Market Dynamics:
A high incidence of uterine fibroids among women drives the demand for the uterine fibroid treatment across the U.S., thereby, driving the market growth. For instance, in March 2020, according to the U.S. Library of Congress, an estimated 26,000,000 women between the ages of 15 and 50 have uterine fibroids in the U. S. Uterine fibroids may cause significant morbidity through their presence in the uterus and pelvic cavity, causing significant pelvic pain, iron-deficiency anemia, miscarriages, infertility, and heavy bleeding, which is one of the most common and bothersome symptoms. This is expected to drive the demand for advanced treatment of uterine fibroid throughout the U.S..
Additionally, the emergence of highly effective treatment for uterine fibroid also drives the market growth. For instance, according to the Society of Interventional Radiology March 2019 publication, Uterine fibroid embolization (UFE) is a minimally-invasive treatment for uterine fibroids that is less painful, preserves the uterus and allows women to get back to their lives sooner than surgical options. UFE is performed through a tiny incision. Using real-time imaging, an interventional radiologist guides a catheter into the uterine arteries and then releases tiny particles to block the blood flow to the fibroid tumors. UFE technique is expected to effectively treat uterine fibroids with fewer post-procedure complications compared to myomectomy.
Benefits You Gain With Our Research Methodology:
Develop your Business strategies to refine the profits in near team.
Grow your Business profit ratio through our analytics report.
Acquire the valuable insights on different products, services and technology along with their obsolescence nature in the foreseen period.
Gain and upper hand on competition by having competitive financial, growth and economic data.
Identity future threats by our accurate forecasting strategies.
Obtain Go-To market strategy to increase your chances in the existing market.
Buy Now This Business Strategic Report to Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/10/22/
About Foster Market Research:
Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data.
Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.
Contact Us:
1701 Royal Lane, #1306, Dallas Tx-75229 Phone: +1 469 4981929 Email: [email protected]
0 notes
Text
Embolization Particle Industry 2020 Global Market Growth, Trends, Revenue, Share and Demands Research Report
New study Embolization Particle Market research report covering the current trend and effect on the business of COVID-19. The global Embolization Particle Market Report offers valuable data on this report with the aid of fragmenting the market into different segments. Various vital elements are covered in the global Embolization Particle Market research report, including regional industry perspectives, geographic developments, country-level assessment, competitive environment, market share analysis of companies, and top company proreports. The study on the Embolization Particle Market fine-tuns the variety of the key features for which companies are analyzed. The study utilizes various techniques such as surveys, interviews, and existing discussions with participants, end-users, and industry leaders to analyze the global specialty malt industry.
Major Players Covered in this Report are: Boston Scientific Corporation, Medtronic, plc, Terumo Corporation, Sirtex Medical Limited, Stryker Corporation, Merit Medical Systems, Inc.
Request a Sample Copy to Understand the Impact of COVID-19 on Embolization Particle market@ https://www.marketgrowthinsight.com/sample/117278
Factors and Embolization Particle Market execution are analyzed using quantitative and qualitative approaches to give a consistent picture of current and future trends in the boom. The study also allows for a detailed market analysis focused primarily on geographic locations. The Global Embolization Particle Market Report offers statistical graphs, estimates, and collateral that explain the state of specific trade within the local and global scenarios.
The purpose of the Embolization Particle Market analysis is to provide a well-structured overview of significant innovations, discoveries coupled with the technological advancements that occur in the global industry. The study also provides descriptions of the impact these findings may have on the growth prospects of the Global Embolization Particle Market during the review period. In addition, our analysts provided a comprehensive overview of the macro as well as the micro indicators combined with the report's existing and expected industry developments. The report provides an insight into the aspects within this segment that may encourage or demote the expansion of the Global Embolization Particle Industry. The Embolization Particle report segment also helps the consumer understand the life cycle of the desired product, along with the application reach of the product across industries and the prominent technological developments that will assess the level of competition for the product around the world. In summary, the segment provides the current business position, thus retaining in the projection period 2020 as the beginning year and 2025 as the ending year.
Embolization Particle Market Classification by Types:
Radioembolization Spheres
Microspheres
Drug eluting Beads
Embolization Particle Market Size by Application:
Peripheral Vascular Disease
Neurology
Oncology
Urology
To get Incredible Discounts on this Premium Report@ https://www.marketgrowthinsight.com/discount/117278
The Embolization Particle report provides separate comprehensive analytics for North America, Europe, China, Japan, Middle East & Africa, India, South America, and Others. Annual estimates and forecasts are provided for the period 2015 through 2025. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Embolization Particle in US$ Million.
In this study, the years considered to estimate the market size of Embolization Particle are as follows:
History Year 2015-2019 Base Year 2020 Estimated Year 2020 Forecast Year 2020-2025
Reasons to Purchase this Report:
Comprehensive analysis of the Embolization Particle Market growth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies Embolization Particle market restraints and boosters.
Identifies all the possible segments present in the Embolization Particle market to aid organizations in strategic business planning.
If You Have Any Query, Ask Our Experts@ https://www.marketgrowthinsight.com/inquiry/117278
About Us-
Market Growth Insight 100% Subsidiary of Exltech Solutions India, is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 30000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends.
Contact Us:
Direct Line: +1 3477675477 (US) Email: [email protected] Web: https://www.marketgrowthinsight.com
0 notes
Text
Interventional Oncology Solutions Market to Showcase Attractive Growth Opportunities Worldwide
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat cancer in pancreas, liver, lung, breast, prostrate, kidney, and bones. Interventional oncology procedures are segmented into two procedures i.e. diagnostic and therapeutic. Therapeutic procedures can be further categorized into ablation techniques and embolization techniques. Ablation techniques uses some form of heat to destroy tumor. Embolization Technique occludes blood vessels, which feed tumors and further destroy the tumor by means of ischemia. Both these procedures are minimally invasive and there is minimal pain, complications, and discomfort with rapid recovery.
Interventional Oncology Solutions Market Drivers:-
Increasing popularity of minimal invasive procedures due to advantages such as minimal risk of infection, shorter stay in the hospitals, minimal complications, minimal pain, and faster recovery as compared to invasive surgeries, is a major factor supporting the global interventional oncology solutions market growth over the forecast period. Moreover, increasing product launches is expected to aid in growth in interventional oncology solutions market size. For instance, in 2017, Terumo Corporation, a Japan-based company, launched Quirem Spheres microspheres. This is used to treat solid liver tumors, which cannot be removed by surgery completely. Microspheres consists of a radioactive isotope Holium-166. Quirem Spheres and can also be visualized in low concentrations by means of SPECT (Single Photon Emission Computed Tomography) and MRI. This feature allows doctors to carefully assess distribution of microspheres in the organs such as liver, which enables in accurate assessment of treatment after SIRT (Selective Internal radiation Therapy) procedure. Half-life of Quirem Spheres is 26.8 hours, which means that within the first 4 days more than 90% of the radiation is delivered, which is followed by implantation procedure.
Interventional Oncology Solutions Market Regional Analysis:-
North America is expected to hold dominant position in the global interventional oncology solutions market over the forecast period. This is owing to increasing mergers & acquisition and research collaboration between manufacturers and universities in the region to develop novel products. For instance, in 2015, Boston Scientific enhanced its interventional oncology portfolio by acquiring spherical embolic technologies, Embozene and Oncozene microspheres, which were developed by Celo Nova Biosciences. These spheres are designed to prevent flow of blood to the targeted tissue and also reduce growth of tumors. Moreover, in 2016, Philips collaborated with Yale School of Medicine to bring new innovations in the field of interventional oncology. Liver cancer is one of their main focus areas, as TACE (Trans arterial Chemoembolization), an alternative and minimally invasive technique to treat liver cancer patients, it has shown better results than chemotherapy. TACE is a minimally invasive procedure which is performed in interventional radiology to restrict a tumors blood supply. Small embolic particles which are coated with chemotherapeutic drugs are injected through a catheter into the arteries which supply blood to the tumor. Chemotherapeutic drugs block the supply of blood and induce cytotoxicity i.e. attacking the tumor in several ways. TACE involves administration of embolic beads and chemotherapy agents to gradually block arteries feeding the tumor, which further causes death of the tumor.
Europe interventional oncology solutions market is expected to exhibit high growth over the forecast period, owing to high cancer prevalence in the region. According to a study conducted by World Health Organization (WHO) in 2016, Europe has over 753,600 people diagnosed with cancer. Furthermore, key players in the region are focusing on launching new products, which is another factor supporting growth of the market. For instance, in 2017, Elekta, a Sweden-based company, launched Elekta Unity MR-linac, which relies on a Philips 1.5 Tesla MRI Machine. During therapy sessions, the machine produces diagnostic level image quality. This device provides more precise treatment, which includes targeting of higher doses on sensitive areas containing multiple organs and also observation of radiation affecting tumor. One of the most important application of this device is the functional MRI, which helps doctor to observe how the treatment is working on the tumor and it also helps to evaluate the rate of blood flow through the tumor, which indicates if the tissue is alive or is showing some change due to the therapy.
Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/1884
Interventional Oncology Solutions Market Key Players:-
Key players operating in the global interventional oncology solutions market include Boston Scientific Corporation, Angio Dynamics, C.R. Bard, Best Medical International, Pfizer, MedWaves, Health Tronics, Sitex, BTG, Merit Medical Systems, Perseon, Cook Medical, Accuracy, Vascular Solutions, TERUMO, ALPINION MEDICAL SYSTEMS, Varian medical, Smith & Nephew, Profound Medical, BOVIE MEDICAL, and Baylis Medical.
Interventional Oncology Solutions Market Taxonomy:-
By Therapy-
Radiation Therapy
External Radiation Therapy
Internal Radiation Therapy
Ablation
Radiofrequency Ablation
Cryo Ablation Therapy
Microwave Ablation Therapy
Particle Embolization
Radio Embolization
Microspheres
Drug Eluting Beads
Polyvinyl Alcohol Particles
By End Users:-
Hospitals
Specialty Clinics
Ambulatory Surgery Centers
Others
By Region:-
North America
Europe
Latin America
Asia Pacific
Middle East
Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
0 notes